Arcutis Biotherapeutics, Inc. - 8-K Filing

Arcutis Biotherapeutics expands Board of Directors with appointment of former AbbVie CMO Dr. Robert Scott (Items: 7.01 Regulation FD Disclosure)

3 articles from 1 source · updated October 29, 2026, 11:46 UTC

Coverage

• SAIA INC - 8-K Filing SEC EDGAR · October 29, 2026, 11:46 UTC
• Arcutis Biotherapeutics, Inc. - 4 Filing SEC EDGAR · October 28, 2026, 20:21 UTC
• Arcutis Biotherapeutics, Inc. - 8-K Filing SEC EDGAR · October 28, 2026, 13:04 UTC